Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Sara Nazha"'
Autor:
Samer Shamout, Sara Nazha, Alice Dragomir, Richard Baverstock, Jacques Corcos, Lysanne Campeau
Publikováno v:
Spinal Cord. 61:269-275
Autor:
Bimal Bhindi, Simon Tanguay, Frédéric Pouliot, Christina Canil, Sebastien J. Hotte, Alan I. So, Alice Dragomir, Daniel Heng, Rodney H. Breau, Nicholas Power, Jean-Baptiste Lattouf, Sara Nazha, Aaron R. Hansen, Ricardo A. Rendon, Antonio Finelli, Adrian Fairey, Lori Wood, Christian K. Kollmannsberger, Georg A. Bjarnason, Naveen S. Basappa, Anil Kapoor
Publikováno v:
European Urology Focus. 8:1703-1710
Background Treatment options for metastatic renal cell carcinoma (mRCC) include cytoreductive nephrectomy (CN) and systemic therapy (ST). Results from the CARMENA and SURTIME trials suggest that CN before ST may not be the optimal treatment strategy
Autor:
Sara Nazha, A. Senay, Alice Dragomir, J. Delisle, Suzanne N Morin, Sylvie Perreault, Julio Cesar B. Fernandes
Publikováno v:
Journal of Bone and Mineral Research. 36:459-468
This study aimed to assess the cost-utility of a Fracture Liaison Service (FLS) with a systematic follow-up according to patients' follow-up compliance trajectories. The Lucky Bone™ FLS is a prospective cohort study conducted on women and men (≥4
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Kidney cancer is placed third in urologic cancers in Canada, right behind prostate and bladder cancer. Many new therapeutic options are being developed in the metastatic ...
Autor:
Daniel Heng, Denis Soulières, Sara Nazha, Lori Wood, Christian Kollmannsberger, Anil Kapoor, Éric Lévesque, Michael A.S. Jewett, Alice Dragomir, Martin Neil Reaume, Georg A. Bjarnason, Naveen S. Basappa, Simon Tanguay
Publikováno v:
Clinical Drug Investigation. 38:1155-1165
The development of new targeted therapies in kidney cancer has shaped disease management in the metastatic phase. Our study aims to conduct a cost-utility analysis of sunitinib versus pazopanib in first-line setting in Canada for metastatic renal cel
Publikováno v:
Neurourology and Urodynamics. 37:2195-2203
AIMS To investigate the long-term cost-utility of the artificial urinary sphincter (AUS) compared with Transobturator Retroluminal Sling (AdVance) in the treatment of patients with severe post prostatectomy stress urinary incontinence (PPSUI) from a
Autor:
E. Lévesque, Sara Nazha, Michael A.S. Jewett, D.Y.C. Heng, Alice Dragomir, Georg A. Bjarnason, Christian Kollmannsberger, Naveen S. Basappa, Lori Wood, Anil Kapoor, Simon Tanguay, Denis Soulières, N. Reaume
Publikováno v:
Current Oncology
Volume 25
Issue 6
Pages 4103-584
Volume 25
Issue 6
Pages 4103-584
Outside of randomized controlled clinical trials, the understanding of the effectiveness and costs associated with targeted therapies for metastatic renal cell carcinoma (mrcc) is limited in Canada. The purpose of the present study was to use real-wo
Autor:
Alice Dragomir, Sara Nazha, Christian K. Kollmannsberger, Alan I. So, Daniel Y.C. Heng, Naveen S. Basappa, Lori Wood, Simon Tanguay, Denis Soulières, Antonio Finelli, Aaron R. Hansen, Ricardo A. Rendon, Anil Kapoor, Frédéric Pouliot
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 38:799.e1-799.e10
Background Surgical resection of metastasis can be integrated in the management of metastatic renal cell carcinoma (mRCC) as it can contribute to delay disease progression and improve survival. Objective This study assessed the impact of complete met
Publikováno v:
The Journal of Urology. 203:e1088
INTRODUCTION AND OBJECTIVE:The development of immunotherapies (IOs) for the treatment of bladder cancer in first and second-line increased the economic burden of this disease. We aimed to use an ec...